Explore this test

  • Test Details
  • Lab Values
  • Clinical Significance
  • Treatment Options
DOWNLOAD SPECIMEN PREP FLYER

Explore this test

Test Code 257(includes VLDL-C and triglycerides)

Test Details

Very Low-Density Lipoprotein Cholesterol/Triglycerides Ratio (VLDL-C/TG)

This is a ratio calculated by dividing very low density lipoprotein cholesterol by triglycerides. A high ratio is linked to abnormal lipid metabolism and increased risk of CVD events.

Methodology

The VLDL-C ratio is  calculated as follows:
VLDL-C/TG ratio  = VLDL-C/TG

Patient Preparation

8-12 hour fast prior to collection. Patient may drink water only.

Preferred Specimen

1.0 mL serum (0.5 mL minimum) collected in serum separator tube (SST/Tiger Top)

Alternate Specimen

1.0 mL EDTA plasma (0.5 mL minimum) collected in plasma separator tube (Pearl Top)

Transport Temperature

Refrigerated (ship on frozen cold packs)

Stability

Refrigerated: 7 days

Lab Values

Lab Values

Very Low-Density Lipoprotein Cholesterol/Triglycerides Ratio (VLDL-C/TG)

  • Optimal: <0.20
  • Borderline: 0.20 – 0.30
  • Increased Risk: >0.30
Test Details
Clinical Significance

Clinical Significance

Very Low-Density Lipoprotein Cholesterol/Triglycerides Ratio (VLDL-C/TG)

  • When the VLDL-C/TG ratio is > 0.30 it indicates the presence of cholesterol-rich chylomicron and VLDL remnant lipoproteins, which increase CVD risk.1
  • A VLDL-C/TG ratio of > 0.30 has been associated with an increased risk of CVD and dysbetalipoproteinemia often associated with the apoE2/2 genotype.

References:

  1. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49-73.
Lab Values
Treatment Options

Treatment Options

Very Low-Density Lipoprotein Cholesterol/Triglycerides Ratio (VLDL-C/TG)

  • Lifestyle modification
  • Statins
  • Niacin
  • Fibrates
  • Cholesterol absorption inhibitors
Clinical Significance